期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
影像生物标志物与贝伐珠单抗联合标准治疗对胶质母细胞瘤患者诊断及疗效的临床研究 被引量:3
1
作者 张文燕 王翠英 赵宝帅 《陕西医学杂志》 CAS 2016年第8期1055-1056,共2页
目的:探讨影像生物标志物联合贝伐珠单抗在胶质母细胞瘤诊断及治疗中的应用价值。方法:选择我院收治的胶质母细胞瘤(GBM)患者38例,作为研究对象。采用随机数表法将其分为BEV组(n=20)与TMZ组(n=18),所有患者均接受同步放化疗,BE... 目的:探讨影像生物标志物联合贝伐珠单抗在胶质母细胞瘤诊断及治疗中的应用价值。方法:选择我院收治的胶质母细胞瘤(GBM)患者38例,作为研究对象。采用随机数表法将其分为BEV组(n=20)与TMZ组(n=18),所有患者均接受同步放化疗,BEV组患者采用贝伐珠单抗治疗,TMZ组选择替莫唑胺治疗,治疗后行DSC-MRI、DCE-MRI及PET检查,观察患者治疗前及治疗后各时间段影像生物标志物指标的变化,并统计两组患者治疗效果及生活质量。结果:两组患者近期疾病有效率、疾病控制率比较均存在显著差异(P〈0.05);两组患者T0时刻rCBV、rCBF、Ktrans比较无显著差异,随着时间的延长,T1-T3时刻两组患者rCBV、rCBF、Ktrans均呈下降趋势,并且组间比较存在显著差异。结论:通过MRI检查观察胶质母细胞瘤患者影像生物标志物可初步判断患者病情程度,并且联合贝伐珠单抗治疗可准确评估患者病情改善程度,对指导临床治疗预后具有重要意义。 展开更多
关键词 胶质母细胞瘤/诊断 胶质母细胞瘤/治疗 @影像生物标志物 @贝伐珠单抗
下载PDF
NIR-Ⅱ fluorescence visualization of ultrasound-induced blood–brain barrier opening for enhanced photothermal therapy against glioblastoma using indocyanine green microbubbles 被引量:5
2
作者 Simin Liang Dehong Hu +5 位作者 Guofeng Li Duyang Gao Fei Li Hairong Zheng Min Pan Zonghai Sheng 《Science Bulletin》 SCIE EI CAS CSCD 2022年第22期2316-2326,共11页
Focused ultrasound(FUS)-induced blood–brain barrier(BBB) opening is crucial for enhancing glioblastoma(GBM) therapies. However, an in vivo imaging approach with a high spatial–temporal resolution to monitor the BBB ... Focused ultrasound(FUS)-induced blood–brain barrier(BBB) opening is crucial for enhancing glioblastoma(GBM) therapies. However, an in vivo imaging approach with a high spatial–temporal resolution to monitor the BBB opening process in situ and synchronously is still lacking. Herein, we report the use of indocyanine green(ICG)-dopped microbubbles(MBs-ICG) for visualizing the FUS-induced BBB opening and enhancing the photothermal therapy(PTT) against GBM. The MBs-ICG show bright fluorescence in the second near-infrared window(NIR-II), ultrasound contrast, and ultrasound-induced size transformation properties. By virtue of complementary contrast properties, MBs-ICG can be successfully applied for cerebral vascular imaging with NIR-II fluorescence resolution of ~168.9 lm and ultrasound penetration depth of ~7 mm. We further demonstrate that MBs-ICG can be combined with FUS for in situ and synchronous visualization of the BBB opening with a NIR-II fluorescence signal-tobackground ratio of 6.2 ± 1.2. Finally, our data show that the MBs-ICG transform into lipid-ICG nanoparticles under FUS irradiation, which then rapidly penetrate the tumor tissues within 10 min and enhance PTT in orthotopic GBM-bearing mice. The multifunctional MBs-ICG approach provides a novel paradigm for monitoring BBB opening and enhancing GBM therapy. 展开更多
关键词 NIR-II fluorescence imaging ULTRASOUND Blood-brain barrier Brain tumor Photothermal therapy
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部